These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 27618)

  • 1. Positive chronotropic effect of threo-3,4-dihydroxyphenylserine as a precursor of noradrenaline in rat isolated atria.
    Araki H; Cheng JT; Ohmura I; Tanaka C
    J Pharm Pharmacol; 1978 Jul; 30(7):456-8. PubMed ID: 27618
    [No Abstract]   [Full Text] [Related]  

  • 2. Age-related changes in the chronotropic effect and the enzymic decarboxylation of L-threo-3,4-dihydroxphenylserine in the rat heart.
    Araki H; Fujiwara H; Tanaka C
    J Pharm Pharmacol; 1981 Dec; 33(12):778-82. PubMed ID: 6121849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DL-threo-DOPS as a precursor of noradrenaline.
    Reches A; Jackson-Lewis V; Fahn S
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Nov; 331(2-3):202-8. PubMed ID: 3937060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diuretic effect of L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, in rats and mice.
    Katsube J; Kato T; Katsuyama M; Maeda Y; Nishikawa S; Nakamura M
    J Pharm Pharmacol; 1986 Jul; 38(7):533-4. PubMed ID: 2875157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
    Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
    J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased brain concentration of homovanillic acid in rats treated with threo-3,4-dihydroxyphenylserine.
    Edwards DJ; Sedlock ML
    J Pharm Pharmacol; 1982 Oct; 34(10):685-6. PubMed ID: 6128399
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
    Karai N; Kato T; Katsuyama M; Nakamura M; Katsube J
    Life Sci; 1987 Jun; 40(23):2261-8. PubMed ID: 3108598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular effects of D,L-threo-dihydroxyphenylserine in cats.
    Redmond DE; Olander R; Maas JW
    Toxicol Appl Pharmacol; 1975 Nov; 34(2):301-8. PubMed ID: 1209627
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of L-threo-dihydroxyphenylserine on norepinephrine metabolism in rat brain.
    Semba J; Takahashi R
    Psychiatry Res; 1985 Aug; 15(4):319-26. PubMed ID: 3934694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS), an immediate precursor of norepinephrine, on the cerebral blood flow in rats.
    Sato E; Irie T; Katsube J
    Jpn J Pharmacol; 1987 Jan; 43(1):91-3. PubMed ID: 3106684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat heart.
    Ohmura I; Inagaki C; Araki H; Tanaka C
    Jpn J Pharmacol; 1978 Oct; 28(5):747-53. PubMed ID: 31501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of 3,4-dihydroxyphenylserine on the concentration of brain noradrenaline and the level of plasma growth hormone of rats.
    Hirai M; Matsuoka Y; Nakajima T; Sano I
    Med J Osaka Univ; 1975 Sep; 26(12):51-9. PubMed ID: 1228392
    [No Abstract]   [Full Text] [Related]  

  • 13. Pressor effect of L-threo-3,4-dihydroxyphenylserine in rats.
    Araki H; Tanaka C; Fujiwara H; Nakamura M; Ohmura I
    J Pharm Pharmacol; 1981 Dec; 33(12):772-7. PubMed ID: 6121848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of L-threo-dihydroxyphenylserine on spinal reflexes and decerebrate rigidity in rats.
    Ono H; Tanabe M; Nakamura T; Nagano N; Fukuda H
    Gen Pharmacol; 1988; 19(3):369-72. PubMed ID: 3138156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressor action of L-threo-dihydroxyphenylserine in the rat nucleus tractus solitarii.
    Miyamae T; Yue JL; Goshima Y; Misu Y
    Eur J Pharmacol; 1996 Apr; 300(1-2):105-8. PubMed ID: 8741173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
    Fujiwara H; Inagaki C; Ikeda Y; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
    Kato T; Katsuyama M; Karai N; Nakamura M; Katsube J
    Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-threo-DOPS, an L-noradrenaline precursor, on locus coeruleus-originating neurons in spinal trigeminal nucleus.
    Sasa M; Ohno Y; Nabatame H; Yoshimura N; Takaori S
    Brain Res; 1987 Sep; 420(1):157-61. PubMed ID: 3119149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal by L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS), a L-norepinephrine precursor of reserpine- or tetrabenazine-induced hypothermia.
    Katsuyama M; Kato T; Karai N; Nakamura M; Katsube J
    Arch Int Pharmacodyn Ther; 1986 Sep; 283(1):61-70. PubMed ID: 3099671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preferential decarboxylation of L-threo-3,4-dihydroxyphenylserine in rat renal tissues.
    Soares-da-Silva P
    Gen Pharmacol; 1993 Jan; 24(1):75-81. PubMed ID: 8482506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.